thrombocytopenia/phosphatase

Nuoroda įrašoma į mainų sritį

Pasirinkite rūšiavimo tipą

9 rezultatus

COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

Design: Retrospective cohort study that will review the data of patients seen in participating centers with a confirmed or probable diagnosis of COVID-19 between March and April 2020. Those patients who test positive for nasopharyngeal exudate for SARS-CoV-2 will be considered a confirmed case using

Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

- Optional tumor biopsy will be obtained prior to Day 1 of CPI-0610 administration. - CPI-0610 will be administered 200mg orally once a daily for 14 consecutive days followed by a 7-day break. The 14 days of CPI-0610 dosing and the 7-day break together constitute 1 cycle of treatment. The dose will

Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

1.0 Background While atrial fibrillation (AF) is the most common sustained cardiac arrhythmia requiring therapy, it is also associated with increased risk of stroke, heart failure, myocardial infarction, dementia, and death. The number of Americans affected with AF is expected to surge to nearly 16

Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

Primary biliary cirrhosis (PBC) is a slowly progressive cholestatic disease associated with the development of cirrhosis and liver failure that may justify liver transplantation. Ursodeoxycholic acid (UDCA) is currently the only drug approved specifically for the treatment of PBC. However, one out

Study of the Pathophysiological Mechanisms Involved in Bleeding Events

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

Introduction: Lowe syndrome (LS), also known as oculocerebrorenal syndrome of Lowe (OCRL), is a rare X-linked condition characterized by congenital cataracts, defective renal tubule cell function, muscular hypotonia and variable degrees of mental retardation. Patients with LS require frequent

Idarubicin Versus High Dose Daunorubicin in Acute Myelogenous Leukemia (AML)

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

1. INDUCTION CHEMOTHERAPY - For patients randomized to receive Idarubicin (Arm I, AI regimen) will be given Cytarabine 200 mg/m2/day by continuous iv infusion over 24 hours daily for 7 days (D 1-7) along with Idarubicin 12 mg/m2/day iv daily for 3 days (D 1-3). - For patients randomized to receive

A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC)

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

Synopsis All enrolled patients will receive 3.5 Gy per fraction (five fractions per week) at the following levels; Dose escalation by 7 Gy in 2 fractions to maximum of 63 Gy, as follows: Dose Level I: 3.5 Gy for 12 fractions (42 Gy total) Dose Level II*: 3.5 Gy for 14 fractions (49 Gy total) Dose

Peripheral Blood Stem Cells Obtained From Normal Volunteers for Studying Retroviral Vector Mediated Gene Transfer Into Primitive Hematopoietic Cells and Vector Mediated Transgene Expression in Mature Hematopoietic Lineages

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

The peripheral blood has been established as a source of hematopoietic stem cells, providing an alternative source to bone marrow for hematopoietic reconstitution of patients with oncologic, hematologic, and genetic diseases. Although apheresis is less efficient than bone marrow harvesting for

A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

PROTOCOL SUMMARY Study design: Phase II trial of monthly Doxil® and vinorelbine on day 1 and 2 in women with metastatic breast cancer. Treatment plan: Patients will continue therapy, until they have unacceptable toxicity or disease progression. Primary endpoint: Response rate Secondary endpoints:

Prisijunkite prie mūsų
„Facebook“ puslapio

Herbal & Natural Medicine

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu

Dirba 55 kalbomis
Žolelių gydymas, paremtas mokslu
Vaistažolių atpažinimas pagal vaizdą
Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
Skaitykite mokslines publikacijas, susijusias su jūsų paieška
Ieškokite vaistinių žolelių pagal jų poveikį
Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus

Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais